Preskoči na sadržaj
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Jezik
Sva polja
Naslov
Autor
Tema
Signatura
ISBN/ISSN
Oznaka
Pronađi
Napredno
Cetuximab plus Irinotecan as t...
Citiraj ovo
Pošalji tekstualnu poruku
Pošalji ovo e-mailom
Ispiši
Izvezi zapis
Izvezi u RefWorks
Izvezi u EndNoteWeb
Izvezi u EndNote
Stalna poveznica
Cetuximab plus Irinotecan as third line chemotherapy for metastatic colorectal cancer
Bibliografski detalji
Glavni autori:
Moe, M
,
Micallef, R
,
Pwint, T
,
Maughan, T
,
Mort, D
,
Wagstaff, J
Format:
Journal article
Izdano:
2008
Primjerci
Opis
Slični predmeti
Prikaz za djelatnike knjižnice
Slični predmeti
Regorafenib versus Cetuximab plus Irinotecan in Third-line Metastatic Colorectal Cancer in Iran: A Model-based Cost-utility Analysis
od: Meysam Seyedifar, i dr.
Izdano: (2024-10-01)
EGFR related mutational status and association to clinical outcome of third-line cetuximab-irinotecan in metastatic colorectal cancer
od: Frifeldt Sanne K, i dr.
Izdano: (2011-03-01)
Panitumumab versus cetuximab in combination with irinotecan in refractory metastatic colorectal cancer
od: Maria Ignez Freitas Melro Braghiroli, i dr.
Izdano: (2024-01-01)
Cetuximab therapy in first-line metastatic colorectal cancer and intermittent palliative chemotherapy: review of the COIN trial.
od: Adams, R, i dr.
Izdano: (2008)
First‐line therapy of bevacizumab plus chemotherapy versus cetuximab plus chemotherapy for metastatic colorectal cancer patients with mucinous adenocarcinoma or mucinous component
od: Yu‐Wen Zhou, i dr.
Izdano: (2021-05-01)